关注
Gniewomir Latacz
Gniewomir Latacz
Jagiellonian University Medical College, Faculty of Pharmacy
在 uj.edu.pl 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Natural selenium particles from Staphylococcus carnosus: Hazards or particles with particular promise?
EC Estevam, S Griffin, MJ Nasim, P Denezhkin, R Schneider, R Lilischkis, ...
Journal of hazardous materials 324, 22-30, 2017
672017
Design, synthesis, and anticonvulsant activity of new hybrid compounds derived from 2-(2, 5-dioxopyrrolidin-1-yl) propanamides and 2-(2, 5-dioxopyrrolidin-1-yl) butanamides
K Kamiński, M Zagaja, JJ Łuszczki, A Rapacz, M Andres-Mach, G Latacz, ...
Journal of medicinal chemistry 58 (13), 5274-5286, 2015
592015
Novel multitarget-directed ligands aiming at symptoms and causes of Alzheimer’s disease
A Więckowska, T Wichur, J Godyń, A Bucki, M Marcinkowska, A Siwek, ...
ACS chemical neuroscience 9 (5), 1195-1214, 2018
572018
Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2, 5-dioxopyrrolidin-1-yl) propanamide and 2-(2, 5-dioxopyrrolidin-1-yl …
K Kamiński, A Rapacz, JJ Łuszczki, G Latacz, J Obniska, ...
Bioorganic & medicinal chemistry 23 (10), 2548-2561, 2015
562015
Aryl-1, 3, 5-triazine derivatives as histamine H4 receptor ligands
D Łażewska, M Więcek, J Ner, K Kamińska, T Kottke, JS Schwed, ...
European journal of medicinal chemistry 83, 534-546, 2014
522014
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction
T Felicetti, R Cannalire, D Pietrella, G Latacz, A Lubelska, G Manfroni, ...
Journal of medicinal chemistry 61 (17), 7827-7848, 2018
472018
The 1, 3, 5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment
G Latacz, A Lubelska, M Jastrzębska-Więsek, A Partyka, MA Marć, ...
International Journal of Molecular Sciences 20 (14), 3420, 2019
452019
In the search for a lead structure among series of potent and selective hydantoin 5‐HT7R agents: The drug‐likeness in vitro study
G Latacz, A Lubelska, M Jastrzębska‐Więsek, A Partyka, A Sobiło, ...
Chemical biology & drug design 90 (6), 1295-1306, 2017
452017
Antinociceptive effects of novel histamine H3 and H4 receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse
K Popiolek‐Barczyk, D Łażewska, G Latacz, A Olejarz, W Makuch, H Stark, ...
British journal of pharmacology 175 (14), 2897-2910, 2018
432018
KA-11, a novel pyrrolidine-2, 5-dione derived broad-spectrum anticonvulsant: its antiepileptogenic, antinociceptive properties and in vitro characterization
K Socała, S Mogilski, M Pieróg, D Nieoczym, M Abram, B Szulczyk, ...
ACS chemical neuroscience 10 (1), 636-648, 2018
392018
MF-8, a novel promising arylpiperazine-hydantoin based 5-HT7 receptor antagonist: In vitro drug-likeness studies and in vivo pharmacological evaluation
G Latacz, A Lubelska, M Jastrzębska-Więsek, A Partyka, K Kucwaj-Brysz, ...
Bioorganic & medicinal chemistry letters 28 (5), 878-883, 2018
392018
Chlorophenoxy aminoalkyl derivatives as histamine H3R ligands and antiseizure agents
K Kuder, D Łażewska, G Latacz, JS Schwed, T Karcz, H Stark, ...
Bioorganic & medicinal chemistry 24 (2), 53-72, 2016
392016
Multifunctional hybrid compounds derived from 2-(2, 5-dioxopyrrolidin-1-yl)-3-methoxypropanamides with anticonvulsant and antinociceptive properties
M Abram, M Zagaja, S Mogilski, M Andres-Mach, G Latacz, S Baś, ...
Journal of medicinal chemistry 60 (20), 8565-8579, 2017
342017
The study of cellular cytotoxicity of argireline-an anti-aging peptide.
M Grosicki, G Latacz, A Szopa, A Cukier, K Kieć-Kononowicz
Acta Biochimica Polonica 61 (1), 2014
342014
Selenazolinium salts as “small molecule catalysts” with high potency against ESKAPE bacterial pathogens
K Witek, M Nasim, M Bischoff, R Gaupp, P Arsenyan, J Vasiljeva, M Marć, ...
Molecules 22 (12), 2174, 2017
332017
Aspects of a distinct cytotoxicity of selenium salts and organic selenides in living cells with possible implications for drug design
E Estevam, K Witek, L Faulstich, M Nasim, G Latacz, ...
Molecules 20 (8), 13894-13912, 2015
332015
Search for a 5-CT alternative. In vitro and in vivo evaluation of novel pharmacological tools: 3-(1-alkyl-1 H-imidazol-5-yl)-1 H-indole-5-carboxamides, low-basicity 5-HT 7 …
G Latacz, AS Hogendorf, A Hogendorf, A Lubelska, JM Wierońska, ...
MedChemComm 9 (11), 1882-1890, 2018
312018
Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands
K Szczepańska, T Karcz, S Mogilski, A Siwek, KJ Kuder, G Latacz, ...
European journal of medicinal chemistry 152, 223-234, 2018
302018
Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats
B Sadek, A Saad, G Latacz, K Kuder, A Olejarz, T Karcz, H Stark, ...
Drug design, development and therapy 10, 3879, 2016
302016
Novel naphthyloxy derivatives–potent histamine H3 receptor ligands. Synthesis and pharmacological evaluation
D Łażewska, M Kaleta, S Hagenow, S Mogilski, G Latacz, T Karcz, ...
Bioorganic & medicinal chemistry 26 (9), 2573-2585, 2018
292018
系统目前无法执行此操作,请稍后再试。
文章 1–20